Single-Cell Transcriptomic Analysis of Livers During NLRP3 Inflammasome Activation Reveals a Novel Immune Niche
D. M. Calcagno, A. Chu, S. Gaul, N. Taghdiri, A. Toomu, A. Leszczynska, B. Kaufmann, A. Wree, L. Geisler, H. M. Hoffman, A. E. Feldstein, K. R. King
Abstract
The NOD-like receptor protein 3 (NLRP3) inflammasome is a central contributor to human acute and chronic liver disease, yet the molecular and cellular mechanisms by which its activation precipitates injury remain incompletely understood. Here, we present single cell transcriptomic profiling of livers from a global transgenic Tamoxifen-inducible constitutively-activated Nlrp3A350V mutant mouse, and we investigate the changes in parenchymal and non-parenchymal liver cell gene expression that accompany inflammation and fibrosis. Our results demonstrate that NLRP3 activation causes chronic extramedullary myelopoiesis marked by an increase in proliferating myeloid progenitors that differentiate into neutrophils, monocytes, and monocyte-derived macrophages, results that were corroborated by flow cytometry and histological staining. We observed prominent neutrophil infiltrates with increased Ly6gHI and Ly6gINT cells exhibiting transcriptomic signatures of granulopoiesis typically found in the bone marrow. This was accompanied by a marked increase in Ly6cHI monocytes differentiating into Cd11bHITim4HIClec4fHI macrophages that express proinflammatory transcriptional programs similar to macrophages of non-alcoholic steatohepatitis (NASH) models. NLRP3 activation also downregulated metabolic pathways in hepatocytes and shifted hepatic stellate cells towards an activated pro-fibrotic state based on expression of collagen and extracellular matrix (ECM) regulatory genes. These results, which highlight abundant neutrophils and extramedullary granulopoiesis define an inflamed and fibrotic hepatic single cell microenvironment, precipitated solely by NLRP3 activation. Clinically, our data support the notion that neutrophils and NLRP3 should be explored as therapeutic targets in NASH-like inflammation.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NLRP3 inflammasome signaling orchestrates hepatic granuloma organization and protective immunity
Isadora M. de Oliveira, Mariana M. Chaves, … Dario S. Zamboni·bioRxiv·Sep 24, 2026
- Chronic NLRP3 inflammasome activation drives neutrophil brain entry and interactions with microglia
Lukas L. Skuja, Sophia M. Guldberg, … Gilbert Di Paolo·bioRxiv·Apr 23, 2026
- The NLRP3/eIF2 axis drives cell cycle progression in acute myeloid leukemia
M. Luciano, C. Blöchl, … J. Horejs-Hoeck·bioRxiv·Jun 25, 2021
- Spatiotemporal proteomic profiling of cellular responses to NLRP3 agonists
Louis Robert Hollingsworth, Priya Veeraraghavan, … J. Wade Harper·bioRxiv·Apr 19, 2024
- Aspartate reduces liver inflammation and fibrosis by suppressing the NLRP3 inflammasome pathway via upregulating NS3TP1 expression
Li Zhou, Jing Zhao, … Jun Cheng·Journal of Personalized MedicinePeer-reviewed·Feb 22, 2023
- A detailed Molecular Network Map and Model of the NLRP3 Inflammasome
M. Krantz, D. Eklund, … A. Hedbrant·bioRxiv·May 31, 2023